Monoclonal antibodies to native HIV type 1 reverse transcriptase and their interaction with enzymes from different subtypes

AIDS Research and Human Retroviruses

Volumn 16, Issue 13, 2000, Pages 1281-1294

  Rytting, A S ^a   Akerblom L ^b   Albert, J ^c,d   Unge, T ^a   Bjorling E ^d   Al Khalili, L ^d   Gronowitz, J S ^a,e   Kallander C F R ^a,e  

^a UPPSALA UNIVERSITY   (Sweden)

^b NATIONAL VETERINARY INSTITUTE   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

^e Cavidi Tech   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ISOENZYME; RNA DIRECTED DNA POLYMERASE;

ANTIVIRAL ACTIVITY; ARTICLE; CROSS REACTION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SPECIFICITY; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNIZATION; MOUSE; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; RETROVIRUS; VIRUS ISOLATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; EPITOPE MAPPING; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HIV-2; HUMANS; IMMUNIZATION; ISCOMS; MICE; RECOMBINANT PROTEINS; VIRUS CULTIVATION;

EID: 0034284506     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/08892220050117041     Document Type: Article

References (55)

1. HIV population dynamics in vivo: Implications for genetic variation, pathogenesis, and therapy
2. Viral dynamics in human immunodeficiency virus type 1 infection
3. Antigenic evidence of the presence of the aberrant HIV-1ant70 virus in Cameroon and Gabon
4. Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes
5. Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate
6. A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon
7. Genetic analysis of human immunodeficiency virus type 1 strains from patients in Cyprus: Identification of a new subtype designated subtype I
8. Identification of a new human immunodeficiency virus type 1 distinct from group M and group O
9. HIV-1 subtype O: Epidemiology, pathogenesis, diagnosis, and perspectives of the evolution of HIV
10. Cloning of HTLV-4 and its relation to simian and human immunodeficiency viruses
11. Structural characterization of reverse transcriptase and endonuclease polypeptides of the acquired immunodeficiency syndrome retrovirus
12. Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV
13. Pol gene diversity of five human immunodeficiency virus type 1 subtypes: Evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D
14. Drug susceptibility of subtypes A, B, C, D, and E human immunodeficiency virus type 1 primary isolates
15. Characterization of the reverse transcriptase of a human immunodeficiency virus type 1 group O isolate
16. Human immunodeficiency virus subtype F reverse transcriptase sequence and drug susceptibility
17. HIV reverse transcriptase inhibiting antibodies detected by a new technique: Relation to p24 and gp41 antibodies, HIV antigenemia and clinical variables
18. Measurement of levels of human immunodeficiency virus type 1 reverse transcriptase (RT) and RT activity-blocking antibody in human serum by a new standardized colorimetric assay
19. High prevalence of serum antibodies to reverse transcriptase in HIV-1-infected individuals
20. Enzyme-linked immunosorbent assays for the measurement of human immunodeficiency virus, type 1 reverse transcriptase antigen and antibodies
21. Differentiation between human immunodeficiency virus type 1 (HIV-1) and HIV-2 isolates by nonradioisotopic reverse transcriptase-typing assay
22. Reverse transcriptase and corresponding activity-blocking antibody for monitoring SIVsm infection in macaques
23. Isolation and characterization of monoclonal antibodies raised against the reverse transcriptase of human immunodeficiency virus type 2 and cross-reactivity with that of type 1
24. A colorimetric reverse transcriptase assay optimized for Moloney murine leukemia virus, and its use for characterization of reverse transcriptases of unknown identity
25. Monoclonal antibodies define linear and conformational epitopes of HIV-1 pol gene products
26. Immunological characterization of the human immunodeficiency virus type 1 reverse transcriptase protein by the use of monoclonal antibodies
27. Structure-function relationships of HIV-1 reverse transcriptase determined using monoclonal antibodies
28. Epitope mapping of HIV-1 reverse transcriptase with monoclonal antibodies that inhibit polymerase and RNase H activities
29. Monoclonal antibody-mediated inhibition of HIV-1 reverse transcriptase polymerase activity. Interaction with a possible deoxynucleoside triphosphate binding domain
30. Generation of neutralizing antibody to the reverse transcriptase of human immunodeficiency virus type 1 by immunizing of mice with an infectious vaccinia virus recombinant
31. A method for combined immunoaffinity purification and assay of HIV-1 reverse transcriptase activity useful for crude samples
32. ISCOM, a novel structure for antigenic presentation of membrane proteins from enveloped viruses
33. Expression, purification, and crystallization of the HIV-1 reverse transcriptase (RT)
34. Increased yield of homogeneous HIV-1 reverse transcriptase (p66/p51) using a slow purification approach
35. Most HIV-1 genetic subtypes have entered Sweden
36. Biological phenotype of HIV type 2 isolates correlates with V3 genotype
37. Formation and characterization of FeLV ISCOMs
38. Detection of feline immunodeficiency virus in saliva and plasma by cultivation and polymerase chain reaction
39. The feline lymphoid cell line MBM and its use for feline immunodeficiency virus isolation and quantitation
40. Antigenic presentation of small molecules and peptides conjugated to a preformed ISCOM as carrier
41. Neutralizing cross-reactive and non-neutralizing monoclonal antibodies to HIV-1 gp120
42. A sensitive assay for the quantification of reverse transcriptase activity based on the use of carrier-bound template and non-radioactive-product detection, with special reference to human-immunodeficiency-virus isolation
43. Two highly antigenic sites in the human immunodeficiency virus type 1 reverse transcriptase
44. Immunostaining complexes: Clinical potential in vaccine development
45. A novel neutralization epitope on the 'thumb' subdomain of human immunodeficiency virus type 1 reverse transcriptase revealed by a monoclonal antibody
46. Characterization of human immunodeficiency virus type 1 reverse transcriptase by using monoclonal antibodies: Role of the C terminus in antibody reactivity and enzyme function
47. Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor
48. Molscript: A program to produce both detailed and schematic plots of protein structures
49. Serotyping HIV type 1 by antibody binding to the V3 loop: Relationship to viral genotype
50. The role of the humoral immune response in HIV infection
51. Subtyping of human immunodeficiency virus type 1 strains by using antibodies specific for the third variable domain (V3) of gp120: Results may be affected by divergent V3 sequences
52. Human immunodeficiency virus type 1 subtypes defined by env show high frequency of recombinant gag genes. The UNAIDS network for HIV isolation and characterization